Neuren Pharmaceuticals
NEU.AX
#5836
Rank
S$1.02 B
Marketcap
$8.04
Share price
-6.72%
Change (1 day)
-55.10%
Change (1 year)

EPS for Neuren Pharmaceuticals (NEU.AX)

EPS in 2023: $1.13

According to Neuren Pharmaceuticals's latest financial reports the company's current EPS (TTM) is $1.13. In 2023 the company made an earnings per share (EPS) of $1.13 an increase over its 2022 EPS that were of $0.001369.

EPS history for Neuren Pharmaceuticals from 2002 to 2023

Annual EPS

Year EPS Change
2023$1.1382396.45%
2022$0.001369-102.13%
2021-$0.06417-27.64%
2020-$0.08869-12.55%
2019-$0.10-446.24%
2018$0.02929-247.23%
2017-$0.01989-85.3%
2016-$0.14-13.42%
2015-$0.1634.36%
2014-$0.12-47.14%
2013-$0.2283.64%
2012-$0.12-28.56%
2011-$0.17-46.5%
2010-$0.31-3690.16%
2009$0.008735-100.76%
2008-$1.15-38.72%
2007-$1.8711.23%
2006-$1.6814.27%
2005-$1.47-42.59%
2004-$2.572.56%
2003-$2.5036.5%
2002-$1.83